Trial
NCT04073134
The CHORAL Flow Study
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Imperial College London
Collaborators
—
Condition
Coronary Artery Disease
Intervention
Evolocumab
Why stopped
Funding withdrawn
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-06